Biomarkers, Tumor

"Biomarkers, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS.

Descriptor ID	D014408
MeSH Number(s)	D23.101.140
Concept/Terms	Biomarkers, Tumor Biomarkers, Tumor Tumor Biomarkers Markers, Biological Tumor Tumor Markers, Biological Markers, Tumor Metabolite Tumor Metabolite Markers Metabolite Markers, Tumor Marker, Tumor Metabolite Metabolite Marker, Tumor Tumor Metabolite Marker Tumor Markers, Biologic Biologic Tumor Markers Markers, Biologic Tumor Marker, Biologic Tumor Biologic Tumor Marker Tumor Marker, Biologic Biochemical Tumor Markers Markers, Biochemical Tumor Marker, Biochemical Tumor Biochemical Tumor Marker Tumor Marker, Biochemical Tumor Markers, Biochemical Carcinogen Markers Markers, Carcinogen Markers, Neoplasm Metabolite Neoplasm Metabolite Markers Marker, Neoplasm Metabolite Metabolite Marker, Neoplasm Neoplasm Metabolite Marker Metabolite Markers, Neoplasm Biological Tumor Markers Biological Tumor Marker Tumor Marker, Biological Marker, Biological Tumor Markers, Tumor Markers, Tumor Tumor Markers Biomarkers, Cancer Cancer Biomarkers

Below are MeSH descriptors whose meaning is more general than "Biomarkers, Tumor".

Chemicals and Drugs [D]
Biological Factors [D23]
Biomarkers [D23.101]
Biomarkers, Tumor [D23.101.140]

Below are MeSH descriptors whose meaning is related to "Biomarkers, Tumor".

Below are MeSH descriptors whose meaning is more specific than "Biomarkers, Tumor".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Biomarkers, Tumor" by people in this website by year, and whether "Biomarkers, Tumor" was a major or minor topic of these publications.

Bar chart showing 414 publications over 31 distinct years, with a maximum of 30 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
1997	2	0	2
1998	2	0	2
1999	1	1	2
2000	0	2	2
2001	3	0	3
2002	5	3	8
2003	5	3	8
2004	5	8	13
2005	8	4	12
2006	4	5	9
2007	9	5	14
2008	10	7	17
2009	6	6	12
2010	7	6	13
2011	9	15	24
2012	11	9	20
2013	9	14	23
2014	20	9	29
2015	17	6	23
2016	8	13	21
2017	10	6	16
2018	13	10	23
2019	17	13	30
2020	11	10	21
2021	11	7	18
2022	0	7	7
2023	0	5	5
2024	6	6	12
2025	8	7	15
2026	4	4	8

Below are the most recent publications written about "Biomarkers, Tumor" by people in Profiles.

Cui W, Xiao H, Wen X, Li C, Bao S, Long Y, Yang X, Wang K, Guo Q, Huang J. CEMs-SELEX: DNAzyme-powered de novo biomarker discovery and noninvasive cancer diagnosis. Sci Adv. 2026 May 29; 12(22):eaee7184.

View in: PubMed
Steiner D, Sultan L, Sullivan T, Liu H, Xiao X, LeClerc A, Melvin S, Alekseyev YO, Liu G, Mazzilli SA, Zhang J, Suzuki K, Rieger-Christ K, Burks EJ, Beane J, Lenburg ME. Vascular invasion-associated gene expression is detectable in pre-surgical biopsies of stage I lung adenocarcinoma. Nat Commun. 2026 Mar 24; 17(1).

View in: PubMed
Rao K, Rao Z, Huang A, Heston S, Wang M, Yildiz-Altay ?, Qutab F, Kwong DA, Gardner HL, Richmond JM, London CA. Peripheral blood mononuclear cell gene expression signatures predict long-term survivorship in canine DLBCL. Sci Rep. 2026 Mar 17; 16(1).

View in: PubMed
Qu W, Jia J, Zhang N, Wang R, Liu Y, Zhang S, Gao H, Tao Y, Jia L, Liu Y, Zhao J. Oncogenic role of PHF23 in gastric cancer progression. Funct Integr Genomics. 2026 Mar 04; 26(1).

View in: PubMed
Ribas-Filho JM, N Doelken E, Tripathi S, Polat B, Lissner R, B?eldicke T, Ribas CAPM, Malafaia O, Gasser M, Waaga-Gasser AM. ALDH1 and ALCAM as emerging biomarkers in personalized rectal cancer therapy. Arq Bras Cir Dig. 2026; 38:e1920.

View in: PubMed
Tang X, Liu L, Gao M, Duan P, Li S, Yuan Z, Xia Q, Xi L, Tan Y. Single-cell transcriptomics identifies fibroblast associated immune heterogeneity and prognostic signatures in bladder cancer. Sci Rep. 2026 Feb 03; 16(1):7151.

View in: PubMed
Falc?-Roget J, Basile GA, Janus A, Lillo S, Politi LS, Argasinski JK, Cacciola A. A non-local diffusion magnetic resonance imaging tract density biomarker to stratify, predict, and interpret survival rates in human glioblastoma. Neuro Oncol. 2026 Feb 01; 28(2):564-579.

View in: PubMed
Ribas CAPM, N Doelken E, Tripathi S, Polat B, Lissner R, B?eldicke T, Ribas-Filho JM, Malafaia O, Gasser M, Waaga-Gasser AM. Prognostic and predictive value of AXL and C-MET in patients with rectal cancer. Arq Bras Cir Dig. 2026; 38:e1918.

View in: PubMed
Mateos MK, Ajuyah P, Fuentes-Bolanos N, El-Kamand S, Barahona P, Altekoester AK, Mayoh C, Holliday H, Liu J, Cui L, Pfaff E, Mackay A, Resnick AC, Pinese M, Lau LMS, Khuong-Quang DA, Dias K, Goudie C, Salkeld A, Rokita JL, Jones DTW, Juretic N, Hayden E, Pfister SM, Kramm CM, Blattner-Johnson M, Jabado N, Tsoli M, Vittorio O, Mueller S, Guo Y, Tucker K, Waszak SM, Perreault S, Jones C, Wong-Erasmus M, Cowley MJ, Ziegler DS. Germline analysis of an international cohort of pediatric diffuse midline glioma patients. Neuro Oncol. 2025 Sep 08; 27(7):1849-1863.

View in: PubMed
Van TTV, Tran TH, Nguyen THH, Nguyen VTC, Vo DH, Nguyen GTH, Nguyen TH, To KS, Nguyen AL, Tran CHA, Jasmine TX, Vo TL, Nai THT, Tran TT, Truong MH, Tran NC, Le TL, Nguyen THN, Tu NH, Tran TS, Le BT, Tang VP, Nguyen PTN, Nguyen KT, Ho VC, Nguyen XV, Doan NNT, Tran TT, Tran TMT, Tran VU, Le MP, Vu TL, Tieu BL, Nguyen HTP, Nguyen LHD, Phan NM, Van Phan T, Do TTT, Dao TH, Tang HS, Nguyen DS, Giang H, Phan MD, Nguyen HN, Vo DH, Tran LS. Multimodal analysis of cell-free DNA enhances differentiation of early-stage breast cancer from benign lesions and healthy individuals. BMC Biol. 2025 Aug 20; 23(1):259.

View in: PubMed

People

Explore

Similar Concepts

Top Journals